About T-lymphocyte activation antigen CD80
T-lymphocyte activation antigen CD80 (CD80) is a protein
from Homo sapiens identified by UniProt accession
P33681, 288 residues long.
MolForge cross-references it against 0 known binders and
682 disease associations.
Target properties
| Protein name | T-lymphocyte activation antigen CD80 |
| UniProt accession | P33681 |
| Gene | CD80 |
| Organism | Homo sapiens |
| Length | 288 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (2)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (682)
Diseases linked to this target (Open Targets).
- rheumatoid arthritis · score 0.60
- psoriatic arthritis · score 0.53
- juvenile idiopathic arthritis · score 0.53
- acute graft vs. host disease · score 0.50
- immune system disease · score 0.46
- COVID-19 · score 0.45
- dermatomyositis · score 0.45
- diabetes mellitus · score 0.39
- cancer · score 0.39
- primary biliary cirrhosis · score 0.39
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P33681-F1 | alphafold | PREDICTED | 86.14 | — |
Amino-acid sequence (288 residues)
MGHTRRQGTS PSKCPYLNFF QLLVLAGLSH FCSGVIHVTK EVKEVATLSC GHNVSVEELA QTRIYWQKEK KMVLTMMSGD MNIWPEYKNR TIFDITNNLS IVILALRPSD EGTYECVVLK YEKDAFKREH LAEVTLSVKA DFPTPSISDF EIPTSNIRRI ICSTSGGFPE PHLSWLENGE ELNAINTTVS QDPETELYAV SSKLDFNMTT NHSFMCLIKY GHLRVNQTFN WNTTKQEHFP DNLLPSWAIT LISVNGIFVI CCLTYCFAPR CRERRRNERL RRESVRPV
Explore T-lymphocyte activation antigen CD80 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets